Clinical Trial Detail

NCT ID NCT04493619
Title PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon

ovary epithelial cancer

uterine cancer

ovarian cancer

cervical cancer

vulva cancer

peritoneum cancer

fallopian tube cancer

vaginal cancer


Carboplatin + PLX2853


Age Groups: adult senior

Additional content available in CKB BOOST